Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

September-October 2023; Volume 37,Issue 5

Reviews

  • Open Access
    Pathogenesis of Endometriosis: Focus on Adenogenesis-related Factors
    PIETRO G. SIGNORILE, ALFONSO BALDI, ROSA VICECONTE, ANDREA RONCHI and MARCO MONTELLA
    In Vivo September 2023, 37 (5) 1922-1930; DOI: https://doi.org/10.21873/invivo.13288
  • Open Access
    Pectoralis Major Muscle Morbidity After Submuscular Silicone-based Breast Reconstruction: A Systematic Review
    ANGELIKI STAMOULI, SOPHOCLES LANITIS and MICHAEL KONTOS
    In Vivo September 2023, 37 (5) 1931-1939; DOI: https://doi.org/10.21873/invivo.13289

Experimental Studies

  • Open Access
    Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma
    JENNIFER L. LEITING, MATTHEW C. HERNANDEZ, JOHN R. BERGQUIST, JENNIFER A. YONKUS, AMRO M. ABDELRAHMAN, MICHAEL S. TORBENSON, NGUYEN H. TRAN, THORVARDUR R. HALFDANARSON, RONDELL P. GRAHAM, RORY L. SMOOT and MARK J. TRUTY
    In Vivo September 2023, 37 (5) 1940-1950; DOI: https://doi.org/10.21873/invivo.13290
  • Open Access
    In Vitro Carbon Ion Beam and Gemcitabine Chemoradiation in a Mucoepidermoid Carcinoma Cell Line
    THOMAS SCHNEIDER, FELIX ZWICKER, PETER ERNST HUBER, JÜRGEN DEBUS and HENRIK HAUSWALD
    In Vivo September 2023, 37 (5) 1951-1959; DOI: https://doi.org/10.21873/invivo.13291
  • Open Access
    Renieramycin T Derivative DH_22 Induces p53-dependent Apoptosis in Lung Cancer Cells
    INDIANA GITA ANGGRAENI, ZIN ZIN EI, DAIKI HOTTA, MASASHI YOKOYA and PITHI CHANVORACHOTE
    In Vivo September 2023, 37 (5) 1960-1966; DOI: https://doi.org/10.21873/invivo.13292
  • Open Access
    Active-phase Plasma Alkaline Phosphatase Isozyme Activity Is a Sensitive Biomarker for Excessive Fructose Intake
    YUSUKE SUZUKI, DAIGO YOKOYAMA, CHIZURU MATSUURA, KAZUMA KONDO, TAISHI SHIMAZAKI, KATSUNORI RYOKE, AKIO KOBAYASHI and HIROYUKI SAKAKIBARA
    In Vivo September 2023, 37 (5) 1967-1974; DOI: https://doi.org/10.21873/invivo.13293
  • Open Access
    Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells
    HIRAYUKI ENOMOTO, TAKASHI NISHIMURA, SHINYA FUKUNUSHI, HIDEYUKI SHIOMI and HIROKO IIJIMA
    In Vivo September 2023, 37 (5) 1975-1979; DOI: https://doi.org/10.21873/invivo.13294
  • Open Access
    Role of Mir-452-5p Overexpression in Epithelial–Mesenchymal Transition (EMT) in Early-stage Colorectal Cancer
    YUKIKO KOYAMA, SHINTARO FUJIHARA, TAIGA CHIYO, TAKANORI MATSUI, SAE HAMAYA, KOJI FUJITA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, HISAKAZU IWAMA and TSUTOMU MASAKI
    In Vivo September 2023, 37 (5) 1980-1990; DOI: https://doi.org/10.21873/invivo.13295
  • Open Access
    Humanized PD-1 Knock-in Mice Reveal Nivolumab’s Inhibitory Effects on Glioblastoma Tumor Progression In Vivo
    CHUN-YU CHIANG, MENG-CHU HUANG, SHIH-CHONG TSAI, FEI-TING HSU, TSAI-LAN LIAO, JEI-HWA YU, TZU-HSIANG LIN, HUA-HSIH HUANG and PEN-AN LIAO
    In Vivo September 2023, 37 (5) 1991-2000; DOI: https://doi.org/10.21873/invivo.13296
  • Open Access
    Effects of Chitosan on Chondrocytes Derived from Human Nasal Septal Cartilage
    YU-HSUN CHIU, I-CHENG CHEN, TZU-HAN LIN, TAI-HORNG YOUNG and HSU-WEI FANG
    In Vivo September 2023, 37 (5) 2001-2005; DOI: https://doi.org/10.21873/invivo.13297
  • Open Access
    The Role of Box A of HMGB1 in Enhancing Stem Cell Properties of Human Mesenchymal Cells: A Novel Approach for the Pursuit of Anti-aging Therapy
    ZIN ZIN EI, APIWAT MUTIRANGURA, WANATCHAPORN ARUNMANEE and PITHI CHANVORACHOTE
    In Vivo September 2023, 37 (5) 2006-2017; DOI: https://doi.org/10.21873/invivo.13298
  • Open Access
    Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis
    TING-YU HSIEH, SHAN-WEN LUI, JENG-WEI LU, YEN-CHEN CHEN, TING-CHUN LIN, WUN-LONG JHENG, YI-JUNG HO and FENG-CHENG LIU
    In Vivo September 2023, 37 (5) 2018-2027; DOI: https://doi.org/10.21873/invivo.13299
  • Open Access
    Therapeutic Effect of Human Adipocyte-derived Stem Cell-derived Exosomes on a Transgenic Mouse Model of Parkinson’s Disease
    LUNG CHAN, WAYNE HSU, KAI-YUN CHEN, WEU WANG, YI-CHIEH HUNG and CHIEN-TAI HONG
    In Vivo September 2023, 37 (5) 2028-2038; DOI: https://doi.org/10.21873/invivo.13300
  • Open Access
    Orthotopic Mouse Models of Urinary Bladder Cancer
    JI-IN NOH, EUN-JUNG AHN, MYUNG-GIUN NOH, KYUNG-SUB MOON, EUIHEON CHUNG, CHAN CHOI, KYUNG-HWA LEE and SUNG SUN KIM
    In Vivo September 2023, 37 (5) 2039-2043; DOI: https://doi.org/10.21873/invivo.13301
  • Open Access
    Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice
    PENGZHEN NIU, WENYU ZHAO, QIONG WANG, JUNZHAO DUAN, JIE ZHU, HANJIANG FU, YONGGE WU, XIAOFEI ZHENG, DAGUANG ZHANG and CHANGHUI GE
    In Vivo September 2023, 37 (5) 2044-2056; DOI: https://doi.org/10.21873/invivo.13302
  • Open Access
    Effects of the Foam Massage Roller on VEGF-A and FGF-2 Blood Levels in Young Men
    ADAM ROSLANOWSKI, ALEKSANDRA PARTYNSKA, KATARZYNA RATAJCZAK-WIELGOMAS, ALICJA KMIECIK, JEDRZEJ GRZEGRZOLKA, PIOTR DZIEGIEL, ADAM JANUSZKO, DARIUSZ LENART and WALDEMAR ANDRZEJEWSKI
    In Vivo September 2023, 37 (5) 2057-2069; DOI: https://doi.org/10.21873/invivo.13303
  • Open Access
    Expression of Apurinic/Apyrimidinic Endonuclease 1 in Colorectal Cancer and its Relation to Tumor Progression and Prognosis
    JI-YUN HONG, HYUNG-HOON OH, SUN-YOUNG PARK, YOUNG-LAN PARK, SUNG-BUM CHO and YOUNG-EUN JOO
    In Vivo September 2023, 37 (5) 2070-2077; DOI: https://doi.org/10.21873/invivo.13304
  • Open Access
    Investigating the Anti-Aging Effects of Caviar Oil on Human Skin
    LINH THI THUY LE, BAEK-KYU KIM, PHAM NGOC CHIEN, KEON-WOO CHOI, HONG-BIN KIM, UI-JAE HWANG, HYO SUN HAN and CHAN-YEONG HEO
    In Vivo September 2023, 37 (5) 2078-2091; DOI: https://doi.org/10.21873/invivo.13305
  • Open Access
    Intensity-dependent Temperature Rise Induced by Local Exposure to 26.5 GHz Quasi-Millimeter-Wave in Rat
    ETSUKO IJIMA, KUN LI, TAKASHI HIKAGE, AKIKO NAGAI, YASUTAKA MURAKAMI, TAKUJI ARIMA, TATSUYA ISHITAKE and HIROSHI MASUDA
    In Vivo September 2023, 37 (5) 2092-2099; DOI: https://doi.org/10.21873/invivo.13306
  • Open Access
    Acupuncture Treatment Improves Transport Stress in Microminipigs Through the Acupoint in Ears
    MOE IJIRI, KOHEI AKIOKA, TAISUKE KITANO, HIROSHI MIURA, HISAYA K. ONO, RYOTA TERASHIMA, YOSHIKAZU FUJIMOTO, TOMOHIDE MATSUO, OSAMU YAMATO and HIROAKI KAWAGUCHI
    In Vivo September 2023, 37 (5) 2100-2104; DOI: https://doi.org/10.21873/invivo.13307
  • Open Access
    Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis
    DONGYA CHEN, JINGFANG XIONG, GAOFENG CHEN, ZHAOLIN ZHANG, YIHUI LIU, JIANJUN XU and HONG XU
    In Vivo September 2023, 37 (5) 2105-2127; DOI: https://doi.org/10.21873/invivo.13308
  • Open Access
    A Preliminary Study of Pharmacokinetics and Pharmacodynamics of Oral Fingolimod in Dogs
    TAESIK YUN, JONG-WOO JEONG, YOONHOI KOO, YEON CHAE, DOHEE LEE, HAKHYUN KIM, SOOCHONG KIM, MHAN-PYO YANG, KYEONG-RYOON LEE and BYEONG-TECK KANG
    In Vivo September 2023, 37 (5) 2128-2133; DOI: https://doi.org/10.21873/invivo.13309

Clinical Studies

  • Open Access
    Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
    YUTARO KUBOTA, QINGHONG HAN, SEI MORINAGA, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    In Vivo September 2023, 37 (5) 2134-2138; DOI: https://doi.org/10.21873/invivo.13310
  • Open Access
    Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab
    MARIA LAURA CANALE, GIANCARLO CASOLO, SARA DONATI, IRMA BISCEGLIA, CHETI PUCCETTI, DOMENICO AMOROSO, ELIO VENTURINI, NICOLA MAUREA, FABIO MARIA TURAZZA and ANDREA CAMERINI
    In Vivo September 2023, 37 (5) 2139-2146; DOI: https://doi.org/10.21873/invivo.13311
  • Open Access
    Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies
    MIOKO MATSUO, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA
    In Vivo September 2023, 37 (5) 2147-2154; DOI: https://doi.org/10.21873/invivo.13312
  • Open Access
    A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes
    DUONG T. TRAN, TRUONG N. PHAM, NHUNG HT NGUYEN, HAU D. TRAN, HUY Q. HOANG, BO HAN and BA X. HOANG
    In Vivo September 2023, 37 (5) 2155-2160; DOI: https://doi.org/10.21873/invivo.13313
  • Open Access
    Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening
    MARIA CENCI, FRANCESCA ROSSI and TIZIANA PISANI
    In Vivo September 2023, 37 (5) 2161-2165; DOI: https://doi.org/10.21873/invivo.13314
  • Open Access
    Complication of Gastric Cancer Surgery: A Single Centre Experience
    MARTA GOGLIA, SARA PEPE, MARCO PACE, LUDOVICA FATTORI, ANDREA MINERVINI, DIEGO GIULITTI, DARIO SIRIMARCO, GAETANO GALLO, GIUSEPPE NIGRI, GIOVANNI RAMACCIATO and PAOLO AURELLO
    In Vivo September 2023, 37 (5) 2166-2172; DOI: https://doi.org/10.21873/invivo.13315
  • Open Access
    Comparison of Distress Scores Before and After Radiotherapy for Prostate Cancer
    STEFAN JANSSEN, CANSU DELIKANLI, NATHAN Y. YU and DIRK RADES
    In Vivo September 2023, 37 (5) 2173-2177; DOI: https://doi.org/10.21873/invivo.13316
  • Open Access
    Comparison of Functional and Morphological Estimates of Vascular Age
    MARTIN SIGL, LAURA WINTER, GERHARD SCHUMACHER, STEFANIE CHRISTINA HELMKE, TETYANA SHCHETYNSKA-MARINOVA, KLAUS AMENDT, DANIEL DUERSCHMIED and ANNA LENA HOHNECK
    In Vivo September 2023, 37 (5) 2178-2187; DOI: https://doi.org/10.21873/invivo.13317
  • Open Access
    Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma
    MIOKO MATSUO, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, MASAHIKO TAURA, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA
    In Vivo September 2023, 37 (5) 2188-2196; DOI: https://doi.org/10.21873/invivo.13318
  • Open Access
    Effect of the Minimum Inhibitory Concentration of Vancomycin on the Clinical Outcome of Enterococcus faecium Bacteremia
    TAKANOBU HOSHI, KEI WATANABE, YUTA FUKUMURA, KOJI MIYAZAKI, MADOKA TAKAHASHI, SAKAE TANIGUCHI, NAOKI WADA, MIKA MIURA, SHOYA KATO, KAZUNORI YAMADA, SATOSHI FUJII and HIDEKI SATO
    In Vivo September 2023, 37 (5) 2197-2202; DOI: https://doi.org/10.21873/invivo.13319
  • Open Access
    Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)
    SHINICHIRO OKAUCHI, GEN OHARA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, TAKESHI NUMATA, RYOTA NAKAMURA, TOMOHIRO TAMURA, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, HIROFUMI SAKURAI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, TAKEO ENDO, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, HIROAKI SATOH, TORU SAKAMOTO and NOBUYUKI HIZAWA
    In Vivo September 2023, 37 (5) 2203-2209; DOI: https://doi.org/10.21873/invivo.13320
  • Open Access
    Importance of the Number and Location of Lymph Node Metastasis in Oropharyngeal Cancer
    MASATO IIDA, TARO MURAI, MAYU KUNO, KENSHIRO OSUMI, MIKIKO NAKANISHI-IMAI, DAI OKAZAKI, TAKAYUKI MURASE, DAISUKE KAWAKITA, SHINICHI IWASAKI, HIROSHI INAGAKI, NATSUO TOMITA, YUTA SHIBAMOTO and AKIO HIWATASHI
    In Vivo September 2023, 37 (5) 2210-2218; DOI: https://doi.org/10.21873/invivo.13321
  • Open Access
    Is There an Association Between Circulating Kisspeptin Levels and Ovarian Reserve in Women of Reproductive Age?
    KONSTANTINOS NIKOLETTOS, NIKOLAOS VLAHOS, OLGA PAGONOPOULOU, NIKOS NIKOLETTOS, KONSTANTINOS ZIKOPOULOS, PANAGIOTIS TSIKOURAS, EMMANOUIL KONTOMANOLIS, CHRISTOS DAMASKOS, NIKOLAOS GARMPIS and BYRON ASIMAKOPOULOS
    In Vivo September 2023, 37 (5) 2219-2223; DOI: https://doi.org/10.21873/invivo.13322
  • Open Access
    Cetuximab Plus Concurrent Radiotherapy in Patients With Nasopharyngeal Carcinoma
    MORIYASU YAMAUCHI, YUKI SATO, TOMOYA ISHIDA, AKIMICHI MINESAKI, ERIKO SHIMAZAKI and YUICHIRO KURATOMI
    In Vivo September 2023, 37 (5) 2224-2228; DOI: https://doi.org/10.21873/invivo.13323
  • Open Access
    Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
    JIRI BLAZEK, PETR HOSEK, KAROLINA HRABCOVA, MONIKA BRATOVA, JURAJ KULTAN, MICHAL HRNCIARIK, MARKETA CERNOVSKA, PETRA ZEMANOVA, JANA KREJCI, LEONA KOUBKOVA, MAREK STASTNY and MARTIN SVATON
    In Vivo September 2023, 37 (5) 2229-2236; DOI: https://doi.org/10.21873/invivo.13324
  • Open Access
    Efficacy of Percutaneous Direct Puncture Biopsy of Malignant Lung Tumors Contacting to the Pleura
    HIROSHI KODAMA, HARUYUKI TAKAKI, JUNICHI TANIGUCHI, ATSUSHI OGASAWARA, YASUKAZU KAKO, KAORU KOBAYASHI and KOICHIRO YAMAKADO
    In Vivo September 2023, 37 (5) 2237-2243; DOI: https://doi.org/10.21873/invivo.13325
  • Open Access
    Patient Preferences With Regard to Care Structures for Cervical or Vulvar Dysplasia in Certified Dysplasia Clinics in Germany
    LAURA BERGER, ELKE CRAMER, CHRISTEL WEIß, MARC SÜTTERLIN and SASKIA SPAICH
    In Vivo September 2023, 37 (5) 2244-2252; DOI: https://doi.org/10.21873/invivo.13326
  • Open Access
    Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer
    HIROSHI TAMAGAWA, AYAKO TAMAGAWA, TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, AYA KATO, NATSUMI KAMIYA, KAZUKI OTANI, MASAKATSU NUMATA, KEISUKE KAZAMA, JYUNYA MORITA, MIE TANABE, SHIZUNE ONUMA, HARUHIKO CHO, SHO SAWAZAKI, TAKASHI OHSHIMA, NORIO YUKAWA, KENJI MITSUDO, AYA SAITO and YASUSHI RINO
    In Vivo September 2023, 37 (5) 2253-2259; DOI: https://doi.org/10.21873/invivo.13327
  • Open Access
    Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study
    KENGO UMEHARA, KAORI YAMA, KEISUKE GOTO, TAKANOBU HOSHI, TOMOAKI HATAKEYAMA, MARIKO ISAJI, SHINYA TAKADA, KAYO YAMAGISHI, KOZO MINO and HIDEKI SATO
    In Vivo September 2023, 37 (5) 2260-2267; DOI: https://doi.org/10.21873/invivo.13328
  • Open Access
    Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases
    TOSHIHIKO MOTOHARA, KENSUKE YAMAMURA, HIDEAKI MIYAMOTO, SHIGENORI UENO, HIROSHI TAKENO, YASUNORI NAGAYAMA, ERI ODA, RYUICHI KARASHIMA, NOBUYUKI OZAKI, TATSUNORI MIYATA, KOSUKE MIMA, HIROHISA OKABE, TAKATOSHI ISIKO and TORU BEPPU
    In Vivo September 2023, 37 (5) 2268-2275; DOI: https://doi.org/10.21873/invivo.13329
  • Open Access
    Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study
    YU-NAN HUANG, JING-YANG HUANG, WEN-LING LIAO, SHANG-LUN CHIANG, KAI-WEN LIU, DA-TIAN BAU, CHUNG-HSING WANG and PEN-HUA SU
    In Vivo September 2023, 37 (5) 2276-2283; DOI: https://doi.org/10.21873/invivo.13330
  • Open Access
    Assessing the Risk of Stroke in the Elderly in the Context of Long-COVID, Followed Through the Lens of Family Medicine
    ANDRADA FLORINA MOLDOVAN, IOANA MOGA, TITUS MOGA, EVELIN CLAUDIA GHITEA, KATALIN BABES and TIMEA CLAUDIA GHITEA
    In Vivo September 2023, 37 (5) 2284-2295; DOI: https://doi.org/10.21873/invivo.13331
  • Open Access
    Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression
    SI-HYONG JANG, HYUN DEUK CHO, JI-HYE LEE and MEE-HYE OH
    In Vivo September 2023, 37 (5) 2296-2305; DOI: https://doi.org/10.21873/invivo.13332
  • Open Access
    Plasma Circulating Cell-free DNA in Advanced Hepatocellular Carcinoma Patients Treated With Radiation Therapy
    DONG-YUN KIM, EUN-HAE CHO, JAE SIK KIM, EUI KYU CHIE and HYUN-CHEOL KANG
    In Vivo September 2023, 37 (5) 2306-2313; DOI: https://doi.org/10.21873/invivo.13333
  • Open Access
    Serum Testosterone Is Associated With the Severity of COVID-19
    EMA SUZUKI, KOJI KURONUMA, RYOSEI MURAI, YOSHIHIRO FUJIYA, ATSUSHI SAITO, HIROFUMI CHIBA and SATOSHI TAKAHASHI
    In Vivo September 2023, 37 (5) 2314-2319; DOI: https://doi.org/10.21873/invivo.13334
  • Open Access
    Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation
    MASASHI ENDO, YUKIKO FUKUDA, KOHEI OKADA, KAZUNARI OGAWA, MICHIKO NAKAMURA, SATORU TAKAHASHI, ERI MURAKAMI, CHIAKI SHIBAYAMA, MASAHIRO KAWAHARA, KEIKO AKAHANE, RYUTARO ONAGA, TAKAFUMI NAGATOMO, TAKEHARU KANAZAWA, HIROSHI NISHINO, HARUSHI MORI and KATSUYUKI SHIRAI
    In Vivo September 2023, 37 (5) 2320-2326; DOI: https://doi.org/10.21873/invivo.13335
  • Open Access
    Relationship Between SGLT2 Inhibitors and Hemoglobin Levels: A Retrospective Observational Study
    YUKI YOSHIDA, KOHEI TAKAHASHI, RYU HASHIMOTO, TOMONORI OYA and JUNYA SATO
    In Vivo September 2023, 37 (5) 2327-2333; DOI: https://doi.org/10.21873/invivo.13336
  • Open Access
    L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer
    MARTINA ROMANOVÁ, VLADIMÍR ŽIDLÍK, VERONIKA JAVŮRKOVÁ, ADELA KONDÉ, ONDŘEJ ŠIMETKA and JAROSLAV KLÁT
    In Vivo September 2023, 37 (5) 2334-2339; DOI: https://doi.org/10.21873/invivo.13337
  • Open Access
    Association Between Thyroid Radiation Dose and Hypothyroidism in Breast Cancer Patients Undergoing Volumetric Modulated Arc Therapy for Regional Nodal Irradiation
    HYEON KANG KOH, YOUNGHEE PARK, TAERYOOL KOO, KWANG-HO CHEONG, ME YEON LEE, HAE JIN PARK, KYOUNG JU KIM, SOAH PARK, TAEJIN HAN, SEI-KWON KANG, BORAM HA, JAI-WOONG YOON, ME YOUNG KIM and HOONSIK BAE
    In Vivo September 2023, 37 (5) 2340-2346; DOI: https://doi.org/10.21873/invivo.13338
  • Open Access
    A Model for Gastric Cancer Risk Prediction Based on MUC1 Polymorphisms and Health-risk Behaviors in a Vietnamese Population
    NGOC-LAN THI NGUYEN, NGOC DUNG THI DANG, QUY VAN VU, ANH KIM DANG and THANH-VAN TA
    In Vivo September 2023, 37 (5) 2347-2356; DOI: https://doi.org/10.21873/invivo.13339
  • Open Access
    Smoking Status at Time of Diagnosis Affects the Efficacy of Anti-PD-1/L1 Therapy in Patients With Advanced NSCLC
    KYU YEAN KIM, JEONG UK LIM, HYE SEON KANG, JU SANG KIM, SUNG KYOUNG KIM, SEUNG JOON KIM, SANG HAAK LEE and CHANG DONG YEO
    In Vivo September 2023, 37 (5) 2357-2364; DOI: https://doi.org/10.21873/invivo.13340
  • Open Access
    Predictors of Outcomes in Patients With Clinically Lymph Node Positive Prostate Cancer After Definitive Radiotherapy
    TAE HYUN KIM, DONG-YUN KIM and JAE-SUNG KIM
    In Vivo September 2023, 37 (5) 2365-2370; DOI: https://doi.org/10.21873/invivo.13341
  • Open Access
    Highlighting the Advantages and Benefits of Non-NSAID Treatment After Total Knee Arthroplasty: A Cross-sectional Study
    GELU FLORIN MURVAI, CALIN TUDOR HOZAN, CALIN MAGHERU, GHEORGHE SZILAGYI, MADALIN BULZAN, VIORELA ROMINA MURVAI, SIMONA CAVALU and TIMEA CLAUDIA GHITEA
    In Vivo September 2023, 37 (5) 2371-2380; DOI: https://doi.org/10.21873/invivo.13342
  • Open Access
    COVID-19-related Floating Thrombus in the Ascending Aorta – A Case Report
    ROXANA CARMEN GEANA, REZA NAYYERANI, RAZVAN PETRU DRAGULESCU, IOANA MARINICA, NICOLAE BACALBASA, IRINA BALESCU, CAMELIA DIACONU, VLAD ANTON ILIESCU, VICTOR CAUNI and OVIDIU STIRU
    In Vivo September 2023, 37 (5) 2381-2386; DOI: https://doi.org/10.21873/invivo.13343
  • Open Access
    Age, Sex, Metabolic and Pharmacologic Factors May Predict Nonresponse Status to Rheumatoid Arthritis Therapies
    LILIANA BORDEAN, MONICA CHIS, ANCA MARIA CIMPEAN, ALINA CRISTINA BARB, ANDREI ALEXANDRU COSMA, MIHAELA PASCA FENESAN, OVIDIU SIMION COTOI, LAURA NICOLESCU, CRISTIAN MIRCEA NICOLESCU and CLAUDIU AVRAM
    In Vivo September 2023, 37 (5) 2387-2401; DOI: https://doi.org/10.21873/invivo.13344
Back to top
Previous

In this issue

In Vivo: 37 (5)
In Vivo
Vol. 37, Issue 5
September-October 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma
  • Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
  • Renieramycin T Derivative DH_22 Induces p53-dependent Apoptosis in Lung Cancer Cells
  • In Vitro Carbon Ion Beam and Gemcitabine Chemoradiation in a Mucoepidermoid Carcinoma Cell Line
  • Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks
The Antitumor Activities of Flavonoids
Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification
Muscle Regeneration: Cellular and Molecular Events
Radioprotection
Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-eluting Beads: Results of a Phase II Clinical Study
In Vivo

© 2023 In Vivo

Powered by HighWire